NCT01542502View on ClinicalTrials.gov

Pilot Feasibility Study of the Safety and Efficacy of Anakinra in Heart Failure With Preserved Ejection Fraction

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Heart Failure
Interventions
DRUG

Anakinra

Anakinra 100 mg daily subcutaneous injection

DRUG

Placebo

Placebo daily subcutaneous injection

Trial Locations (1)

23298

Virginia Commonwealth University, Richmond

All Listed Sponsors
collaborator

American Heart Association

OTHER

lead

Virginia Commonwealth University

OTHER

NCT01542502 - Pilot Feasibility Study of the Safety and Efficacy of Anakinra in Heart Failure With Preserved Ejection Fraction | Biotech Hunter | Biotech Hunter